Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Featured News
March 10, 2017
Cardiovascular
New blood test may predict cardiovascular events in patients with or without coronary artery disease
March 9, 2017
Cardiovascular
March 9, 2017
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community